Scott A. Hill
Analyst · Sandler O'Neill
Thank you, Kelly. Good morning, everyone, and thank you for joining us today. I'll begin on Slide 4, where I'll provide a summary of our first half performance. Despite the continued headwinds of low volatility, which resulted in futures volumes declining 19% in the first half, ICE's consolidated net revenues of $1.5 billion were basically flat year-on-year on a pro forma basis. We expanded adjusted operating margins to 50%, and we grew adjusted earnings per share from continuing operations 2% to $4.38 per share. In addition, during June, we completed the IPO of Euronext and used those proceeds to effectively reduce our adjusted debt-to-EBITDA leverage to our target of 1.5x. We also reached agreements to sell the nonstrategic NYSE Technologies businesses. Then, moving into July, we repurchased 1.8 million shares of our stock for $350 million. And finally, we continue to make good progress on our integration plan, including the successful transition of the Liffe US contracts onto our ICE Futures exchanges. Our improved full year guidance now reflects the achievement of nearly half of our original $500 million synergy target, and we have increased that target to $550 million to reflect additional synergies related to our cash equity and equity options businesses. Our ability to grow earnings in the first half against the backdrop of declining volume is driven by many factors, including a favorable mix of products, diversification across our global markets, continuous product development and our disciplined focus on expense management. Importantly, there remain numerous metrics, from rising open interest levels to customer log-ins, that indicate volume declines are cyclical rather than structural. Open interest across our asset classes grew 5% from the end of 2013, and we established several volume records despite the overall low volatility environment. Please turn to Slide 5, where I will briefly discuss our second quarter results. Consolidated net revenues were $750 million. Adjusted operating expenses were $387 million, and our adjusted operating margin for the quarter was 48%. We also received $15 million in dividends from Cetip in the second quarter, which are reflected in other income. This includes an $11 million annual dividend and $4 million in quarterly interest and dividend payments, reflecting an increased payout ratio and a shift to quarterly versus annual dividend payments in 2014. This quarterly income is an important and recurring return on our investment and our partnership with Cetip. Our tax rate came in towards the higher end of our range at 29% as our business mix this year has shifted more towards the U.S. given the softer volumes in Europe. Adjusted net income attributable to ICE from continuing operations was $243 million, and adjusted earnings per share from continuing operations were $2.10. For the first half of 2014, operating cash flow was $836 million, an increase of 1% versus the pro forma operating cash flows of the 2 companies in the prior 6 months, excluding discontinued operations. During the same period, investments in operational capital expenditures and capitalized software were $87 million. Now let's move to Slide 6, where we detail revenues and expenses for the second quarter. On the left side of the chart, you can see that over 60% of our $750 million in net revenue is made up of transaction and clearing net revenue, which totaled $460 million. Market data revenues were $96 million. This includes Liffe market data revenues, which declined about $6 million from the first quarter as we transitioned to separate data packages for Liffe and Euronext. We expect to recover at least half of that decline in the third quarter. Market data revenues for legacy ICE increased modestly, indicating continued strong interest in these markets. We also generated $83 million in revenue from listings. Excluding the purchase accounting adjustment, listings revenue would have been up 5% year-to-year. Other revenue contributed $111 million in the second quarter. The right side of Slide 6 shows our expense detail. Second quarter adjusted expenses were $387 million and came in below our guidance primarily due to a $6 million R&D state tax credit reflected in compensation expense, which relates to 2012 and '13. While future credits and the timing of such credits depend on the continuing extension of federal R&D tax credits, we expect to receive a recurring benefit for the current and future years. Adjusting for this benefit in the quarter, we would have come in at the low end of the range of our expense guidance. And importantly, adjusted operating margin in the quarter was 48%, reflecting the benefit of the more than $200 million in synergies we've already realized. Moving now to Slide 7. I'll discuss our derivatives revenue and volumes in greater detail. Total futures and options revenue was $329 million on volume that declined 20% year-to-year, reflecting low volatility across most asset classes. This includes European interest rates that declined significantly compared to 2013 volumes, which grew 25%, and against the backdrop of recent ECB rate cuts that have kept short-term interest rates near 0 in the EU. Despite the decline in volumes, open interest trends are encouraging. Open interest was 79 million contracts at the end of the second quarter, a 5% increase from the end of 2013. Excluding natural gas, open interest was 58 million contracts at the end of the second quarter, up 17% from year end. Brent and other oil open interest are at record levels, up 25% and 17%, respectively, at the end of June compared to year end. And interest rates open interest is up 17% year-to-date. And as we've seen before, once volatility and seasonal activity returns, these types of healthy open interest levels generally translate into volume growth. We announced July volumes on Tuesday, and despite declining volumes in energy, our July energy revenues were up versus the prior year and up significantly from the second quarter of this year. This is a tangible example of the growth in Brent OI turning into a meaningful revenue contribution as volatility returns. And the slight RPC decline was due to the typical declines we see related to customer mix during volatile periods and remind us that it's revenue, not RPC, that generates profit. Continuing with our derivatives markets on Slide 8, I'll update you on our CDS business. CDS revenues were $41 million in the second quarter, up 3% year-to-year. This was driven by a 6% increase in clearing revenues to $24 million. In the first half of 2014, we continued to enhance our product set, including clearing for the market iTraxx Senior Financial CDS Index and sovereign CDS instruments on Italy, Portugal, Spain and Ireland. In the course of just a few months, we've cleared $537 billion in gross notional value in these new contracts. Turning next to Slide 9. You will see a summary of the second quarter performance of our U.S. cash equities and U.S. options exchanges. While second quarter volumes in cash equities were down 12% year-to-year, we achieved market share gains both year-on-year and sequentially. And as you will hear from Jeff, we continue to focus on a constructive dialogue with our industry and regulators to reduce market complexity. In our U.S. options business, we also saw muted volumes, resulting in average daily volume declining 21%. Though market share was down year-over-year, market share and RPC were steady sequentially. And as reported on Tuesday, our July volumes were mixed, with U.S. cash equities average daily volume of 1.3 billion down 4% year-over-year but with U.S. equity options average daily volume of 3.6 million rising by 1% year-over-year. Next, on Slide 10, we provide an overview of our cash generation and debt profile. Operating cash flows grew to $836 million during the first half. At June 30, we had $2.1 billion in unrestricted cash. On a trailing 12-month basis, our cash earnings per share were $9.64, which is a 6% increase in cash earnings over the same period in 2013. We calculate cash EPS using operating cash flow less capital expenditures, divided by the weighted average shares outstanding. We believe this is an important metric for investors to consider as it reflects the cash-generative capability of our business. We completed the IPO of Euronext in June and received total net proceeds of $1.9 billion. Following the receipt of the proceeds, we set aside $1.3 billion to repay the June 2015 euro notes when they mature. In addition, the proceeds were also used to reduce our outstanding commercial paper by $563 million during the quarter. As a result, adjusted gross debt-to-EBITDA is 1.5x. Our target debt-to-EBITDA leverage ratio of 1.5x will remain an important focus. However, you'll see us moving around that target from time to time based on the cash flow of the business, the timing of strategic investment opportunities and our capital return program. Please now move to Slide 11, where I'll provide an update on our capital allocation. We remain focused on driving both earnings growth and delivering strong returns by investing in our business while also providing a prudent level of capital return to shareholders, both through dividends and share buybacks. As you can see on Slide 11, capital returns were modest in 2012 and 2013 as we prepared to close the NYX transaction. However, prior to that, from 2008 to 2011, we repurchased nearly $600 million of our common stock. And in July, after using Euronext proceeds to achieve our leverage target, we spent $350 million to repurchase 1.8 million shares of our common stock under our existing $450 million share repurchase plan. And our Board of Directors recently expanded our share repurchase authorization by an additional $600 million. As the chart indicates, based upon our current dividend level and assuming we utilize the remaining $700 million for future share repurchases by the end of 2015, we may return as much as $1.7 billion to shareholders during 2014 and '15 combined, including over $1.1 billion in the next 17 months. Importantly, we believe we can do this while continuing to invest in our existing business and while participating in strategic M&A to drive long-term growth. I'll wrap up on Slides 12 and 13. Slide 12 shows the evolution of our expense base and synergy achievement. The chart begins with the data we provided when we announced the NYSE acquisition in December 2012 and includes adjustments to remove Euronext and NYSE Technologies from the expense base. Importantly, as noted on the first bullet of this slide, after a comprehensive review of the NYSE operations, we have identified an additional $50 million of expense synergies. This includes the technology platform rationalization we discussed last quarter, as well as efficiency gains across other areas of the business. The increased total of $550 million in expense synergies exiting 2016 means we will have reduced the combined company's total expense base by roughly 30% and the NYSE Liffe expense base by well over 40%. Moving to the graph, you will recall that in our November strategic and financial update, we noted $95 million in expense synergies had already been achieved. We subsequently noted that we would achieve between $35 million and $40 million of synergies from the discontinued NYSE Technologies businesses. Adding those 2 together, you get $132 million of synergies achieved and a continuing ops expense base of just over $1.6 billion. Our current full year expense guidance reflects an additional $108 million in synergies versus that new base, bringing the total to $240 million in 2014. And as we exit this year, our first quarter 2015 expenses should reflect a run rate to achieve 70% or $350 million of our original synergies, excluding any additional investments we may make during 2015. You can see that as the synergies increase and as we divest nonstrategic businesses, our total expense base comes down significantly. You can also see this progress in our operating margin, which, as noted previously, was 50% for the first half of 2014. Turning quickly to Slide 13. I'll point out our updated guidance for the third quarter and full year. All guidance completely excludes Euronext and the to-be-sold NYSE Technology businesses. You'll note improvement in virtually every element of our expense guidance. Importantly, you'll also note that D&A is 2x larger than operational CapEx, which is another important factor when considering the cash generation of our business. I'll be happy to answer any questions about our guidance or any other topics during Q&A. For now, though, I'll hand the call over to Jeff.